Cardiac dysfunction and prenatal exposure to venlafaxine
Related Experiment Video
Updated: Mar 22, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Ana R Araújo1, Mónica Marçal2, Madalena Tuna2
1Pediatric Cardiology Department Hospital de Santa Cruz Centro Hospitalar de Lisboa Ocidental Lisboa Portugal.
Abstract:
Venlofaxine, a widely used antidepressant, is known to cause a withdrawal syndrome. We present a case of neonatal transient ventricular dysfunction in a neonate exposed to venlafaxine in utero. Other causes of ventricular dysfunction were excluded. Neonatal ventricular dysfunction can be a possible side effect of maternal use of this drug.
More Related Videos
Related Concept Videos
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Teratogenicity
Drug Toxicity: Risk factors
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Factors Affecting Drug Response: Overview
Antidepressant Drugs: Overview

